Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of MED2005 vs Nitrostat and IV GTN
NCT04008732Phase 1Completed
- Sponsor
- Futura Medical plc
- Start
- Nov 2017
- Primary completion
- Apr 2018
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of MED2005 in erectile dysfunction (ED) (8 arms), sponsored by Futura Medical plc. Primary endpoints: Area Under the Curve from time zero to last measurable concentration at 22 days, Area Under the Curve from time zero to infinity at 22 days and 1 more. Started Nov 2017; status: completed.
02
Drugs
MED2005
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT04008732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04008732.